Humacyte, Inc.
HUMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $598,319 | $293,713 | $217,438 | $289,785 |
| - Cash | $44,937 | $80,448 | $149,772 | $217,502 |
| + Debt | $16,537 | $57,453 | $50,066 | $51,178 |
| Enterprise Value | $569,919 | $270,718 | $117,732 | $123,461 |
| Revenue | $0 | $0 | $1,565 | $1,263 |
| % Growth | – | -100% | 23.9% | – |
| Gross Profit | -$7,190 | -$76,550 | -$6,690 | -$60,078 |
| % Margin | – | – | -427.5% | -4,756.8% |
| EBITDA | -$132,234 | -$96,458 | -$76,368 | -$72,967 |
| % Margin | – | – | -4,879.7% | -5,777.3% |
| Net Income | -$148,701 | -$110,776 | -$11,965 | -$26,477 |
| % Margin | – | – | -764.5% | -2,096.4% |
| EPS Diluted | -1.26 | -1.07 | -0.12 | -0.66 |
| % Growth | -17.8% | -791.7% | 81.8% | – |
| Operating Cash Flow | -$98,122 | -$73,305 | -$71,129 | -$81,190 |
| Capital Expenditures | -$1,572 | -$2,280 | -$1,048 | -$220 |
| Free Cash Flow | -$99,694 | -$75,585 | -$72,177 | -$81,410 |